E-LIB Suche - Ergebnisse für: Haslam, Karl

1

Protracted Clonal Trajectory of a JAK2 V617F-Positive Myelo..:

Langabeer, Stephen E. ; Haslam, Karl ; Smyth, Maria Anne..
Case Reports in Hematology. 2018 (2018) - p. 1-4 , 2018

Link: https://doi.org/10.1155/..

2

International external quality assurance of JAK2 V617F quan..:

Asp, Julia ; Skov, Vibe ; Bellosillo, Beatriz...
Annals of Hematology. 98 (2018) 5 - p. 1111-1118 , 2018

Link: https://doi.org/10.1007/..

3

Who to screen for calreticulin mutations? An audit of real-..:

Haslam, Karl ; Langabeer, Stephen E.
European Journal of Internal Medicine. 40 (2017) - p. e22-e23 , 2017

Link: https://doi.org/10.1016/..

4

Isolated erythrocytosis associated with a CALR mutation:

Langabeer, Stephen E. ; Haslam, Karl ; Flynn, Catherine M.
Blood Cells, Molecules, and Diseases. 66 (2017) - p. 6-7 , 2017

Link: https://doi.org/10.1016/..

5

An acquired NRAS mutation contributes to neutrophilic progr..:

Langabeer, Stephen E. ; Haslam, Karl ; Groarke, Emma.
British Journal of Haematology. 183 (2017) 2 - p. 308-310 , 2017

Link: https://doi.org/10.1111/..

6

The mutant CALR allele burden in essential thrombocythemia ..:

Langabeer, Stephen E. ; Haslam, Karl ; Elhassadi, Ezzat
Blood Cells, Molecules, and Diseases. 65 (2017) - p. 66-67 , 2017

Link: https://doi.org/10.1016/..

7

Characterization of a novel variant BCR–ABL1 fusion transcr..:

Crampe, Mireille ; Haslam, Karl ; Kelly, Johanna..
Hematology/Oncology and Stem Cell Therapy. 10 (2017) 2 - p. 85-88 , 2017

Link: https://doi.org/10.1016/..

8

The JAK2 V617F mutation and thrombocytopenia:

Langabeer, Stephen E. ; Haslam, Karl
Hematology/Oncology and Stem Cell Therapy. 10 (2017) 1 - p. 44-45 , 2017

Link: https://doi.org/10.1016/..

9

Chronic Myeloid Leukemia with an e6a2BCR-ABL1Fusion Transcr..:

Crampe, Mireille ; Haslam, Karl ; Groarke, Emma...
Case Reports in Hematology. 2017 (2017) - p. 1-5 , 2017

Link: https://doi.org/10.1155/..

10

Monitoring Minimal Residual Disease in the Myeloproliferati..:

Haslam, Karl ; Langabeer, Stephen E.
BioMed Research International. 2016 (2016) - p. 1-6 , 2016

Link: https://doi.org/10.1155/..

11

Acute Lymphoblastic Leukemia Arising inCALRMutated Essentia..:

Langabeer, Stephen E. ; Haslam, Karl ; O'Brien, David...
Case Reports in Hematology. 2016 (2016) - p. 1-5 , 2016

Link: https://doi.org/10.1155/..

12

Capricious CALR mutated clones in myeloproliferative neopla..:

Haslam, Karl ; Conneally, Eibhlin ; Langabeer, Stephen E.
Blood Cells, Molecules, and Diseases. 57 (2016) - p. 110-111 , 2016

Link: https://doi.org/10.1016/..

13

CALR mutation profile in Irish patients with myeloprolifera..:

Haslam, Karl ; Conneally, Eibhlin ; Flynn, Catherine M....
Hematology/Oncology and Stem Cell Therapy. 9 (2016) 3 - p. 112-115 , 2016

Link: https://doi.org/10.1016/..

14

Inter-Laboratory Evaluation of a Next-Generation Sequencing..:

Haslam, Karl ; Catherwood, Mark A. ; Dobbin, Edwina...
Molecular Diagnosis & Therapy. 20 (2016) 5 - p. 457-461 , 2016

Link: https://doi.org/10.1007/..

15

Molecular diagnostics of myeloproliferative neoplasms:

Langabeer, Stephen E. ; Andrikovics, Hajnalka ; Asp, Julia...
European Journal of Haematology. 95 (2015) 4 - p. 270-279 , 2015

Link: https://doi.org/10.1111/..